Accelerated evolution of SIV env within the cerebral compartment in the setting of morphine-dependent rapid disease progression

Virology

Volumn 398, Issue 2, 2010, Pages 201-207

  Rivera Amill, Vanessa ^a   Noel Jr , Richard J ^a   García, Yashira ^a   Rivera, Ivelisse ^a   Iszard, Marcus ^c   Buch, Shilpa ^b   Kumar, Anil ^c  

^a PONCE SCHOOL OF MEDICINE   (Puerto Rico)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

Macaque; Morphine; SIV; Viral evolution

Indexed keywords

VIRUS DNA; VIRUS ENVELOPE PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; DISEASE COURSE; GENETIC VARIABILITY; GENOTYPE; MACACA; MOLECULAR EVOLUTION; MORPHINE ADDICTION; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; SURVIVAL TIME; VIRAL GENETICS; VIRUS ENVELOPE;

ANIMALS; BRAIN; BRAIN CHEMISTRY; DISEASE PROGRESSION; EVOLUTION, MOLECULAR; GENE PRODUCTS, ENV; GENOTYPE; MACACA; MOLECULAR SEQUENCE DATA; MORPHINE DEPENDENCE; PHENOTYPE; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 75849154754     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.11.046     Document Type: Article

References (36)

1. CDC issues HIV prevention fact sheets for injection drug use. AIDS Policy Law 17 (2002) 4
2. HIV diagnoses among injection-drug users in states with HIV surveillance-25 states, 1994-2000. MMWR Morb. Mortal. Wkly. Rep. 52 (2003) 634-636
3. Alcabes P., and Friedland G. Injection drug use and human immunodeficiency virus infection. Clin. Infect. Dis. 20 (1995) 1467-1479
4. Amara R.R., Villinger F., Altman J.D., Lydy S.L., O'Neil S.P., Staprans S.I., Montefiori D.C., Xu Y., Herndon J.G., Wyatt L.S., Candido M.A., Kozyr N.L., Earl P.L., Smith J.M., Ma H.L., Grimm B.D., Hulsey M.L., Miller J., McClure H.M., McNicholl J.M., Moss B., and Robinson H.L. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science 292 (2001) 69-74
5. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, 2006. 18. U.S. Department of Health and Human Services (2008), Centers for Disease Control and Prevention
6. Chen M.F., Westmoreland S., Ryzhova E.V., Martin-Garcia J., Soldan S.S., Lackner A., and Gonzalez-Scarano F. Simian immunodeficiency virus envelope compartmentalizes in brain regions independent of neuropathology. J. Neurovirol. 12 (2006) 73-89
7. Chu T.X., and Levy J.A. Injection drug use and HIV/AIDS transmission in China. Cell Res. 15 (2005) 865-869
8. Chuang L.F., Killam Jr. K.F., and Chuang R.Y. Increased replication of simian immunodeficiency virus in CEM x174 cells by morphine sulfate. Biochem. Biophys. Res. Commun. 195 (1993) 1165-1173
9. Clements J.E., Babas T., Mankowski J.L., Suryanarayana K., Piatak Jr. M., Tarwater P.M., Lifson J.D., and Zink M.C. The central nervous system as a reservoir for simian immunodeficiency virus (SIV): steady-state levels of SIV DNA in brain from acute through asymptomatic infection. J. Infect. Dis. 186 (2002) 905-913
10. Cohn J.A. HIV-1 infection in injection drug users. Infect. Dis. Clin. North Am. 16 (2002) 745-770
11. Dehghani H., Puffer B.A., Doms R.W., and Hirsch V.M. Unique pattern of convergent envelope evolution in simian immunodeficiency virus-infected rapid progressor macaques: association with CD4-independent usage of CCR5. J. Virol. 77 (2003) 6405-6418
12. Des J. Psychoactive drug use and progression of HIV infection. J. Acquir. Immune Defic. Syndr. Human Retrovirol. 20 (1999) 272-274
13. Dunfee R., Thomas E.R., Gorry P.R., Wang J., Ancuta P., and Gabuzda D. Mechanisms of HIV-1 neurotropism. Curr. HIV Res. 4 (2006) 267-278
14. Flaherty M.T., Hauer D.A., Mankowski J.L., Zink M.C., and Clements J.E. Molecular and biological characterization of a neurovirulent molecular clone of simian immunodeficiency virus. J. Virol. 71 (1997) 5790-5798
15. Guo C.J., Li Y., Tian S., Wang X., Douglas S.D., and Ho W.Z. Morphine enhances HIV infection of human blood mononuclear phagocytes through modulation of beta-chemokines and CCR5 receptor. J. Investig. Med. 50 (2002) 435-442
16. Hall T.A. BioEdit: a user friendly biological sequence alignment editor and analysis program for windows 95/98/NT. Nucleic Acids Symp. Ser. 41 (2006) 95-98
17. Hicks A., Potula R., Sui Y.J., Villinger F., Pinson D., Adany I., Li Z., Long C., Cheney P., Marcario J., Novembre F., Mueller N., Kumar A., Major E., Narayan O., and Buch S. Neuropathogenesis of lentiviral infection in macaques: roles of CXCR4 and CCR5 viruses and interleukin-4 in enhancing monocyte chemoattractant protein-1 production in macrophages. Am. J. Pathol. 161 (2002) 813-822
18. Kinsey N.E., Anderson M.G., Unangst T.J., Joag S.V., Narayan O., Zink M.C., and Clements J.E. Antigenic variation of SIV: mutations in V4 alter the neutralization profile. Virology 221 (1996) 14-21
19. Kumar R., Torres C., Yamamura Y., Rodriguez I., Martinez M., Staprans S., Donahoe R.M., Kraiselburd E., Stephens E.B., and Kumar A. Modulation by morphine of viral set point in rhesus macaques infected with simian immunodeficiency virus and simian-human immunodeficiency virus. J. Virol. 78 (2004) 11425-11428
20. Kumar S., Tamura K., and Nei M. MEGA3: integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief. Bioinform. 5 (2004) 150-163
21. Kumar R., Orsoni S., Norman L., Verma A.S., Tirado G., Giavedoni L.D., Staprans S., Miller G.M., Buch S.J., and Kumar A. Chronic morphine exposure causes pronounced virus replication in cerebral compartment and accelerated onset of AIDS in SIV/SHIV-infected Indian rhesus macaques. Virology 354 (2006) 192-206
22. Kuwata T., Dehghani H., Brown C.R., Plishka R., Buckler-White A., Igarashi T., Mattapallil J., Roederer M., and Hirsch V.M. Infectious molecular clones from a simian immunodeficiency virus-infected rapid-progressor (RP) macaque: evidence of differential selection of RP-specific envelope mutations in vitro and in vivo. J. Virol. 80 (2006) 1463-1475
23. Nei M., and Gojobori T. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol. Biol. Evol. 3 (1986) 418-426
24. Noel Jr. R.J., and Kumar A. Virus replication and disease progression inversely correlate with SIV tat evolution in morphine-dependent and SIV/SHIV-infected Indian rhesus macaques. Virology 346 (2006) 127-138
25. Noel Jr. R.J., and Kumar A. SIV Vpr evolution is inversely related to disease progression in a morphine-dependent rhesus macaque model of AIDS. Virology 359 (2007) 397-404
26. Noel Jr. R.J., Marrero-Otero Z., Kumar R., Chompre-Gonzalez G.S., Verma A.S., and Kumar A. Correlation between SIV Tat evolution and AIDS progression in cerebrospinal fluid of morphine-dependent and control macaques infected with SIV and SHIV. Virology 349 (2006) 440-452
27. Nyland S.B., Specter S., Im-Sin J., and Ugen K.E. Opiate effects on in vitro human retroviral infection. Adv. Exp. Med. Biol. 437 (1998) 91-100
28. Otto C., Puffer B.A., Pohlmann S., Doms R.W., and Kirchhoff F. Mutations in the C3 region of human and simian immunodeficiency virus envelope have differential effects on viral infectivity, replication, and CD4-dependency. Virology 315 (2003) 292-302
29. Reimann K.A., Li J.T., Veazey R., Halloran M., Park I.W., Karlsson G.B., Sodroski J., and Letvin N.L. A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys. J. Virol. 70 (1996) 6922-6928
30. Reimann K.A., Li J.T., Voss G., Lekutis C., Tenner-Racz K., Racz P., Lin W., Montefiori D.C., Lee-Parritz D.E., Lu Y., Collman R.G., Sodroski J., and Letvin N.L. An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to a chimeric simian/human immunodeficiency virus in rhesus monkeys. J. Virol. 70 (1996) 3198-3206
31. Rivera-Amill V., Noel Jr. R.J., Orsini S., Tirado G., Garcia J.M., Buch S., and Kumar A. Variable region 4 of SIV envelope correlates with rapid disease progression in morphine-exposed macaques infected with SIV/SHIV. Virology 358 (2007) 373-383
32. Ryzhova E., Whitbeck J.C., Canziani G., Westmoreland S.V., Cohen G.H., Eisenberg R.J., Lackner A., and Gonzalez-Scarano F. Rapid progression to simian AIDS can be accompanied by selection of CD4-independent gp120 variants with impaired ability to bind CD4. J. Virol. 76 (2002) 7903-7909
33. Singh D.K., McCormick C., Pacyniak E., Griffin D., Pinson D.M., Sun F., Berman N.E., and Stephens E.B. Pathogenic and nef-interrupted simian-human immunodeficiency viruses traffic to the macaque CNS and cause astrocytosis early after inoculation. Virology 296 (2002) 39-51
34. Suzuki S., Chuang A.J., Chuang L.F., Doi R.H., and Chuang R.Y. Morphine promotes simian acquired immunodeficiency syndrome virus replication in monkey peripheral mononuclear cells: induction of CC chemokine receptor 5 expression for virus entry. J. Infect. Dis. 185 (2002) 1826-1829
35. Thompson J.D., Higgins D.G., and Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22 (1994) 4673-4680
36. Tirado G., and Kumar A. Evolution of SIV envelope in morphine-dependent rhesus macaques with rapid disease progression. AIDS Res. Hum. Retrovir. 22 (2006) 114-119